First Patient Imaged in SOFIE's 18F-FAPI Phase 2 trial
/PRNewswire/ -- SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged the first patient with...
Source: prnewswire.com
Non Randomized Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Non Randomized Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Non Randomized Study Today - Breaking & Trending Today